cerrar
Tagged with access

Amalia Mihai – Market Access Manager, Ipsen Romania
Amalia Mihai, market access manager of Ipsen Romania explains that over the course of 26 years Ipsen has been increasingly helping Romanian patients…

Drugmakers Push Back Against Canada’s New Pricing…
Pushback from drug companies on Canada’s newest drug pricing regulations has led the country's regulatory body to reconsider their implementation.…

Guillaume Recorbet – General Manager, Servier Morocco
Guillaume Recorbet, general manager of Servier in Morocco, explains Servier’s special status in the Moroccan pharma industry as a multinational…

Attila Fejer – General Manager, Eli Lilly Romania
Attila Fejer general manager of Eli Lilly in Romania gives his insights on the “deadly cocktail” of challenging policies that govern the…

A New Era of Access to Innovation in the Czech Republic?
Pharma industry stakeholders are generally quick to suggest that the Czech Republic is one of the most over-regulated markets in Europe, with new or…

Jorge Ruiz Benecke – General Manager, AbbVie Romania
Jorge Ruiz Benecke of AbbVie Romania outlines how the affiliate attained its leading position in the Romanian pharma market, the importance of agility…

Fernando J Cruz – Country President, Novartis Mexico
Novartis Mexico Country President Fernando Cruz outlines the new normal for Mexican healthcare post-regulatory reform, how the company’s global…

Dominika Kovacs – Country Manager, Takeda Romania
Dominika Kovacs, country manager of Takeda Romania, shares her insights on the growing pipeline of the organisation and the anticipated launch of a…

Pharma Faces: Karim Smaira & Kamel Ghammachi of Genpharm
With a combined experience of over five decades in the pharmaceutical industry including senior executive roles at companies such as Merck and…

Dan Zaharescu – Executive Director, ARPIM, Romania
Dan Zaharescu, executive director of the Romanian Association of Pharmaceutical Manufacturers (ARPIM), shares his insights on market access, the need…

Georg Schroeckenfuchs – President, Middle East & Head,…
Georg Schroeckenfuchs, Novartis’ president for the Middle East and head of MEA cluster, is a 32-year veteran of the pharmaceutical industry and…

Martin Minarovič – Country Director, Janssen Czech…
Martin Minarovič, Janssen’s country director Czech Republic, discusses the success factors behind the company’s strong growth, not only in terms…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here